Ursula Eul

Title: Innovations by Ursula Eul

Introduction

Ursula Eul is a notable inventor based in Kahl, Germany. She has made significant contributions to the field of biomedical research, particularly in the area of eye surgery. With a total of 4 patents to her name, her work has the potential to impact therapeutic practices in ophthalmology.

Latest Patents

One of Ursula Eul's latest patents is focused on a method for the disinsertion of the vitreous body from the neural retina of the eye. This involves the use of Chondroitinase II, a protein characterized by an isoelectric point of approximately 8.4-8.45 and an apparent molecular mass of 112 kDa when electrophoresed in a 4 to 20% gradient acrylamide gel in 25 mM Tris/192 mM glycine buffer at pH 8.5 in the presence of about 0.1% (w/v) SDS. The patent details the isolation and purification of this protein, as well as a process for the copurification of chondroitinase I and chondroitinase II proteins produced by Proteus vulgaris. Furthermore, the therapeutic or surgical compositions of these isolated chondroitinases are disclosed, which can be utilized in methods for selectively and completely disinserting the vitreous body from the neural retina.

Career Highlights

Ursula Eul is currently associated with the American Cyanamid Company, where she continues to innovate in her field. Her work has garnered attention for its potential applications in surgical procedures related to eye health.

Collaborations

Ursula has collaborated with notable colleagues such as Kiran M Khandke and John W Gotto, contributing to the advancement of her research and innovations.

Conclusion

Ursula Eul's contributions to the field of ophthalmology through her innovative patents highlight her role as a significant inventor. Her work not only advances scientific understanding but also has the potential to improve surgical techniques in eye care.